WebMar 31, 2024 · I n the wake of the first Alzheimer’s drug approval in nearly two decades, pharmaceutical companies have been reinvigorated in their effort to tackle the neurodegenerative disease. But as ... WebJan 31, 2024 · The French biotech BrainVectis raised €1M in their Series A round last September to fund its preclinical pharmacological tests for their gene therapy approaches to neurodegenerative diseases. Rather than …
The 20 European Biotech Companies to Watch in 2024
WebOct 11, 2024 · Drug powerhouse Sanofi ( SNY 0.83%) is on board, having signed what is potentially a $1 billion deal with the young biotech in 2024. The much larger pharmaceutical company paid $125 million ... WebMay 19, 2024 · With its purchase of Celgene in late 2024, Bristol Myers Squibb ( BMY, $65.60) became a biotech and cancer-fighting machine. BMY has top cancer drugs like Opdivo, Revlimid, Yervoy and Pomalyst ... shara kirby twitch
2024 forecast: 2024 was the year Alzheimer
WebJul 17, 2024 · Thankfully, there are a handful of companies working on treatments for Alzheimer's. With the recent commercialization of Biogen 's drug Aduhelm, investors … WebSep 10, 2024 · Finding a Cure for Alzheimer’s Using Yeast. Founded in 2014, Cambridge, Massachusetts-based Yumanity Therapeutics is also developing their therapies from technology spun-out of MIT. The startup has raised $82.1 million, including $31.1 million from a Series A in June. Yumanity Therapeutics relies on a technology involving … WebMay 21, 2024 · But Remi Barbier, chief executive of another biotech company trying to solve the Alzheimer's puzzle, Cassava Sciences , says a win for Biogen stock could propel others working on Alzheimer's drugs ... shara lecter